How Medicare Part D formulary exception and appeal processes work when a prescribed drug is not covered

Medicare Part D plans manage their own formularies, the lists of drugs each plan agrees to cover. These lists are divided into tiers that determine how much a patient pays. Tier placement differs from plan to plan, and not every drug written by a prescriber will appear on these lists.

When a prescribed drug is not on the formulary

If a medication isn’t covered, or if it has restrictions like prior authorization or quantity limits, a member can file a formulary exception. This request asks the plan to cover the drug as though it were listed, or to move it to a lower cost-sharing tier. The prescriber must show medical necessity, often by explaining that the plan’s covered alternatives don’t work or caused adverse effects.

According to analysis from Drug Channels Institute, changes in formulary design follow how Part D plans manage use and spending. Their research noted that after years of brand-name preference, 2025 formularies moved toward nearly universal generic coverage. That shift shows how plans tighten lists to control costs, leaving some beneficiaries needing exceptions when brand drugs drop off standard coverage.

How the appeal process works

When a plan denies a formulary exception, there’s a structured appeal path. The first stage is a plan-level “redetermination,” where the decision is reviewed again. If that fails, the case moves to an independent review entity. Beyond that, appeals can go before an administrative law judge and higher review bodies. Each level follows set timelines and documentation rules, and beneficiaries can keep adding medical evidence as they go.

This system gives multiple chances to prove medical necessity and challenge denials under Part D. It’s procedural, not automatic, so persistence and strong clinical support make the difference.

This article is for educational purposes only and does not constitute medical, legal, or insurance advice. Patients should review their plan’s evidence of coverage and speak with their prescriber before submitting a formulary exception or appeal.

Sources